ASSESSMENT THE AWARENESS OF THE ELDERLY PATIENT'S KNOWLEDGE AND ATTITUDES AMONG PNEUMOCOCCAL VACCINATION IN KINGDOM OF SAUDI ARABIA 2022
Main Article Content
Keywords
Assessment, Knowledge, attitudes, Patients, PHC, pneumococcal, Immunization, Saudi Arabia.
Abstract
Background Pneumonia represents the leading cause of infection-related death and the fifth cause of overall mortality, in the elderly. With increasing age, the human immune system undergoes characteristic changes which lead to increased incidence and severity of infectious diseases and to sufficient protection following vaccination as antibody response of elderly vaccines are weaker and decline faster. the periodic assessment of adherence to vaccination recommendations is an essential component of any vaccination process, Limited data exist regarding pneumococcal vaccination coverage among the elderly in Middle Eastern countries including Saudi Arabia. The role of vaccine acceptance has become increasingly evident. Yet, large-scale studies of the assessment of the on pneumococcal vaccines acceptance among the elderly are scarce. Hence, we assessed for the first time the current state of knowledge and pneumococcal vaccination coverage among the elderly and the role of health care educational intervention on the attitude, awareness, vaccine acceptance, and prompts for physician consultation regarding pneumococcal vaccines in Saudi Arabia. Aim of the study: To assessment the awareness of the elderly patient's knowledge and attitudes among Pneumococcal vaccination in kingdom of Saudi Arabia 2022. Methods: This cross-sectional study was conducted among 300 participants from health care centers in kingdom of Saudi Arabia. A validated self-administered questionnaire was used. It includes questions on socio demographic variables, knowledge, attitude, and vaccine response, during the August to September 2022. Results: show regarding age most of participants > 80+ were (46.0%), gender majority of participants were(55.0%), marital status the most of participant were (49.0%) married, most of participant Primary school degree or below were (30.0%), occupation most of participant working were (67.0%) while not working were (33.0%), regarding the Pneumococcal vaccination most of participant vaccinated were (67.0%) while Non-Vaccinated were (33.0%). Conclusion: very low pneumococcal vaccination coverage was observed among the elderly in Saudi Arabia , the immunization education and recommendation is suggested to improve pneumococcal vaccine coverage among the elderly, aside from introducing public awareness program about elderly vaccination at state level, free of cost vaccination of elderly individuals should be done pneumococcal vaccination in Saudi Arabia
Downloads
References
1. Roh, E. J., Shim, J. Y., & Chung, E. H. (2022). Epidemiology and surveillance implications of community-acquired pneumonia in children. Clinical and Experimental Pediatrics, 65(12), 563. 2. Kong, F., Li, L., Zhang, D., Lian, B., Liu, X., Ren, S., ... & Cao, L. (2022). Healthy adults with Streptococcus pneumoniae meningitis and Streptococcus pneumoniae subdural abscess: two case reports and a literature review. Journal of International Medical Research, 50(11), 03000605221137470. 3. Cillóniz, C., Garcia-Vidal, C., Ceccato, A., & Torres, A. (2018). Antimicrobial resistance among Streptococcus pneumoniae. Antimicrobial Resistance in the 21st Century, 13-38. 4. von Specht, M., Gabarrot, G. G., Mollerach, M., Bonofiglio, L., Gagetti, P., Kaufman, S., ... & Lopardo, H. A. (2021). Resistance to β-lactams in Streptococcus pneumoniae. Revista Argentina de Microbiología, 53(3), 266-271. 5. Nakano, S., Fujisawa, T., Ito, Y., Chang, B., Suga, S., Noguchi, T., ... & Ichiyama, S. (2016). Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012–2014. Vaccine, 34(1), 67-76. 6. Hedberg, P., Johansson, N., Ternhag, A., Abdel-Halim, L., Hedlund, J., & Nauclér, P. (2022). Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus. BMC Infectious Diseases, 22(1), 1-11. 7. Lyu, Z., Li, J., Zhen, J., Shi, W., Meng, Q., Zhou, W., ... & Dong, F. (2023). A Hospital-Based and Cross-Sectional Investigation on Clinical Characteristics of Pediatric Streptococcus pneumoniae Isolates in Beijing from 2015 to 2021. Infection and Drug Resistance, 499-508. 8. Haessler, S., Guo, N., Deshpande, A., Zilberberg, M. D., Lagu, T., Lindenauer, P. K., ... & Rothberg, M. B. (2022). Etiology, treatments, and outcomes of patients with severe community-acquired pneumonia in a large US sample. Critical care medicine, 50(7), 1063-1071. 9. Poovieng, J., Sakboonyarat, B., & Nasomsong, W. (2022). Bacterial etiology and mortality rate in community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia in Thai university hospital. Scientific Reports, 12(1), 9004. 10. Qu, J., Zhang, J., Chen, Y., Huang, Y., Xie, Y., Zhou, M., ... & Lai, G. (2022). Aetiology of severe community acquired pneumonia in adults identified by combined detection methods: a multi-centre prospective study in China. Emerging microbes & infections, 11(1), 556-566. 11. Schweitzer, V. A., van Heijl, I., Boersma, W. G., Rozemeijer, W., Verduin, K., Grootenboers, M. J., ... & Bonten, M. J. (2022). Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial. The Lancet Infectious Diseases, 22(2), 274-283. 12. Graham, F. F., Finn, N., White, P., Hales, S., & Baker, M. G. (2022). Global perspective of Legionella infection in community-acquired pneumonia: a systematic review and meta-analysis of observational studies. International Journal of Environmental Research and Public Health, 19(3), 1907. 13. Neha, R., Subeesh, V., Beulah, E., Gouri, N., & Maheswari, E. (2020). Postlicensure surveillance of human papillomavirus vaccine using the Vaccine Adverse Event Reporting System, 2006–2017. Perspectives in clinical research, 11(1), 24. 14. Yoshimatsu, Y., & Smithard, D. G. (2022). A paradigm shift in the diagnosis of aspiration pneumonia in older adults. Journal of Clinical Medicine, 11(17), 5214. 15. Tenforde, M. W., Talbot, H. K., Trabue, C. H., Gaglani, M., McNeal, T. M., Monto, A. S., ... & Patel, M. M. (2021). Influenza vaccine effectiveness against hospitalization in the United States, 2019–2020. The Journal of infectious diseases, 224(5), 813-820. 16. Rahman, M. M., Rahman, M. S., Chowdhury, S. R., Elhaj, A., Razzak, S. A., Abu Shoaib, S., ... & Rahman, S. M. (2022). Greenhouse gas emissions in the industrial processes and product use sector of Saudi Arabia—An emerging challenge. Sustainability, 14(12), 7388. 17. Liu, F., Song, S., Ye, X., Huang, S., He, J., Wang, G., & Hu, X. (2022). Oral health-related multiple outcomes of holistic health in elderly individuals: An umbrella review of systematic reviews and meta-analyses. Frontiers in Public Health, 10, 1021104. 18. Toscano, C. M., Valenzuela, M. T., Martinez-Silveira, M. S., Quarti, M. M., da Costa Oliveira, M. T., & de Oliveira, L. H. (2022). Bacterial etiology of pneumonia in children up to 2 months of age: a systematic review. Gates Open Research, 6(15), 15. 19. Tanner, A. R., Dorey, R. B., Brendish, N. J., & Clark, T. W. (2021). Influenza vaccination: protecting the most vulnerable. European Respiratory Review, 30(159). 20. Torres, A., Chalmers, J. D., Dela Cruz, C. S., Dominedò, C., Kollef, M., Martin-Loeches, I., ... & Wunderink, R. G. (2019). Challenges in severe community-acquired pneumonia: a point-of-view review. Intensive care medicine, 45, 159-171. 21. Matanock, A., Lee, G., Gierke, R., Kobayashi, M., Leidner, A., & Pilishvili, T. (2019). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged≥ 65 years: updated recommendations of the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report, 68(46), 1069. 22. Wong, L. P., Alias, H., Danaee, M., Ahmed, J., Lachyan, A., Cai, C. Z., ... & Zhao, Q. (2021). COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: a global survey of 17 countries. Infectious diseases of poverty, 10(1), 1-14. 23. Alreeme, S., Bokhary, H., & Craig, A. T. (2022). Transmission of Antimicrobial Resistant Bacteria at the Hajj: A Scoping Review. International Journal of Environmental Research and Public Health, 19(21), 14134. 24. Schneeberg, A., Bettinger, J. A., McNeil, S., Ward, B. J., Dionne, M., Cooper, C., ... & Halperin, S. A. (2014). Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation. BMC Public Health, 14(1), 1-9. 25. Alyazidi, I. M., Basheikh, M. A., Sait, S., Alharthy, H. A., Rihawi, A. S., Alahmadi, A. A., ... & Bahati, A. M. (2020). Knowledge, attitude and practice about pneumococcal immunization among elderly in Jeddah, Kingdom of Saudi Arabia. Med Sci, 24(102), 483-494. 26. Rosas, L., Rao, K., McGough, C., & Becker, A. (2019). A rare case of Bartonella encephalitis with hemiplegia. Child Neurology Open, 6, 2329048X19826480. 27. Czaicki, N., Bigaj, J., & Zielonka, T. M. (2021). Pneumococcal vaccine in adult asthma patients. Medical and Biomedical Updates, 55-62. 28. Abu-Rish, E. Y., & Barakat, N. A. (2021). The impact of pharmacist-led educational intervention on pneumococcal vaccine awareness and acceptance among elderly in Jordan. Human Vaccines & Immunotherapeutics, 17(4), 1181-1189. 29. Zaraket, H., Melhem, N., Malik, M., Khan, W. M., Dbaibo, G., & Abubakar, A. (2020). Review of seasonal influenza vaccination in the Eastern Mediterranean Region: Policies, use and barriers. Journal of infection and public health, 13(3), 377-384. 30. Hammour, K. A., Farha, R. A., Manaseer, Q., & Al-Manaseer, B. (2022). Factors affecting the public’s knowledge about COVID-19 vaccines and the influence of knowledge on their decision to get vaccinated. Journal of the American Pharmacists Association, 62(1), 309-316. 31. Johnson, D. R., Nichol, K. L., & Lipczynski, K. (2008). Barriers to adult immunization. The American journal of medicine, 121(7), S28-S35. 32. Al-Lahham, A., & Khanfar, N. (2016). Resistance of Streptococcus pneumoniae in Jordanian pediatric carriers, 2015-2016. International Journal of Infectious Diseases, 53, 36. 33. Hariri, N. H. (2022). Seasonal influenza and its vaccine: Knowledge and attitudes of the general population in Makkah city, Saudi Arabia. 34. Pavlič, D. R., Maksuti, A., Podnar, B., & Kokot, M. K. (2020). Reasons for the low influenza vaccination rate among nurses in Slovenia. Primary health care research & development, 21, e38 35. Ababneh, M., Jaber, M., Rababa’h, A., & Ababneh, F. (2020). Seasonal influenza vaccination among older adults in Jordan: prevalence, knowledge, and attitudes. Human Vaccines & Immunotherapeutics, 16(9), 2252-2256. 36. Olatunbosun, O. D., Esterhuizen, T. M., & Wiysonge, C. S. (2017). A cross sectional survey to evaluate knowledge, attitudes and practices regarding seasonal influenza and influenza vaccination among diabetics in Pretoria, South Africa. Vaccine, 35(47), 6375-6386.
Article Sidebar
Article Details
How to Cite
ASSOCIATION OF 25-HYDROXY VITAMIN D3 AND UTERNE FIBROID. 2022 Dec. 28;93(6): 378-389. Available from: https://mattioli.1885journals.com/article/378.html
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.